4th Quarter - Report

ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC) for ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 24, 2017 $140,000 Replaced
4th Quarter - Termination Jul 23, 2018 $140,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Corporate tax policy.

LobbyistCovered position, as disclosed
JOHN S RILEY —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Sunscreen ingredients. Frank Lautenberg Chemical Safety for the 21st Century Act.

LobbyistCovered position, as disclosed
JOHN S RILEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Environment/Superfund ENV

Toxic Substances Control Act.

LobbyistCovered position, as disclosed
JOHN S RILEY —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.